These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17882788)

  • 1. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). CD4 lymphocyte depletion: where have all the cells gone?
    Kim S; Blankson JN
    Hopkins HIV Rep; 2007 Mar; 19(2):10-2. PubMed ID: 17882788
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Management of treatment-naïve patients.
    Gallant JE
    Hopkins HIV Rep; 2007 Mar; 19(2):1-3, 12. PubMed ID: 17882785
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). New data on treatment-experienced patients and drug resistance.
    Lucas GM
    Hopkins HIV Rep; 2007 Mar; 19(2):4-6. PubMed ID: 17882786
    [No Abstract]   [Full Text] [Related]  

  • 4. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Viral hepatitis co-infection in HIV.
    Gebo K; Wilson L
    Hopkins HIV Rep; 2007 Mar; 19(2):7-9. PubMed ID: 17882787
    [No Abstract]   [Full Text] [Related]  

  • 5. Report from Boston: the 10th Conference on Retroviruses and Opportunistic Infections (CROI).
    Gallant JE
    Hopkins HIV Rep; 2003 Mar; 15(2):1-2, 11. PubMed ID: 12739498
    [No Abstract]   [Full Text] [Related]  

  • 6. When to start HAART: still a controversy. Report from Seattle: the 9th Conference on Retroviruses and Opportunistic Infections (CROI).
    Sterling TR
    Hopkins HIV Rep; 2002 Mar; 14(2):1-3. PubMed ID: 12030208
    [No Abstract]   [Full Text] [Related]  

  • 7. Report from the 13th Conference on Retroviruses and Opportunistic Infections (CROI), February 5-8, 2006, Denver, Colorado.
    TreatmentUpdate; 2006; 18(2):4-6. PubMed ID: 17230629
    [No Abstract]   [Full Text] [Related]  

  • 8. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). The New York City patient: a case of progression, pathogenesis, and public health.
    Blankson J
    Hopkins HIV Rep; 2005 Mar; 17(2):10-1. PubMed ID: 16419319
    [No Abstract]   [Full Text] [Related]  

  • 9. Special coverage: Retroviruses Conference 2006. Treatment interruption continues to be controversial strategy in HIV care. CROI studies show mixed results.
    AIDS Alert; 2006 Mar; 21(3):13-6. PubMed ID: 17378059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14th annual retrovirus conference (CROI). New drugs at CROI: the four musketeers. New drugs new targets, new hope.
    Berry J
    Posit Aware; 2007; 18(3):21-3. PubMed ID: 17526109
    [No Abstract]   [Full Text] [Related]  

  • 11. Report from the 14th Retrovirus Conference. Health implications of low CD4-cell counts.
    Henry K
    AIDS Clin Care; 2007 May; 19(5):41-2. PubMed ID: 18401878
    [No Abstract]   [Full Text] [Related]  

  • 12. Left ventricular dysfunction is associated with CD4 lymphocyte count rather than opportunistic infection in human immunodeficiency virus infection.
    Chang WT; Wu CC; Hung CC; Chen MY; Fang CT; Chen WJ; Chuang CY; Lee YT
    J Formos Med Assoc; 2003 Mar; 102(3):158-63. PubMed ID: 12783132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1999 National Conference on Women and HIV/AIDS.
    Proj Inf Perspect; 2000 Mar; (29):17-8. PubMed ID: 12772667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important new findings concerning the pathophysiology and treatment of HIV/AIDS were presented at the 4th Conference on Retroviruses and Opportunistic Infections, held in Washington, DC, January 22-26, 1997.
    Laurence J
    AIDS Patient Care STDS; 1997 Apr; 11(2):58-9. PubMed ID: 11361762
    [No Abstract]   [Full Text] [Related]  

  • 15. Report from the 17th Conference on Retroviruses and Opportunistic Infections. Non-AIDS-related adverse effects of HIV and its treatment.
    Sax PE
    J Watch AIDS Clin Care; 2010 Apr; 22(4):31. PubMed ID: 20480619
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from the 16th Conference on Retroviruses and Opportunistic Infections. No clinical benefit from adding IL-2 to ART.
    Henry K
    J Watch AIDS Clin Care; 2009 Apr; 21(4):29-30. PubMed ID: 19544613
    [No Abstract]   [Full Text] [Related]  

  • 17. Report from the 16th Conference on Retroviruses and Opportunistic Infections. SWITCHMRK: an avoidable raltegravir disaster.
    Albrecht H
    J Watch AIDS Clin Care; 2009 Apr; 21(4):30-1. PubMed ID: 19548330
    [No Abstract]   [Full Text] [Related]  

  • 18. Report from the 17th Conference on Retroviruses and Opportunistic Infections. Intensification of ART--no demonstrable benefit.
    Hicks CB
    J Watch AIDS Clin Care; 2010 Apr; 22(4):31. PubMed ID: 20480929
    [No Abstract]   [Full Text] [Related]  

  • 19. Report from the 16th Conference on Retroviruses and Opportunistic Infections. Timing of ART initiation--still no definitive answers.
    Hicks CB
    J Watch AIDS Clin Care; 2009 Apr; 21(4):30. PubMed ID: 19544614
    [No Abstract]   [Full Text] [Related]  

  • 20. Report from the 11th conference on retroviruses and opportunistic infections. Studies of approved antiretrovirals.
    Feinberg J
    AIDS Clin Care; 2004 Apr; 16(4):26-7. PubMed ID: 15124581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.